Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Moise

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Transfusion Medicine Reviews|April 20, 2025
The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test AccuracyJeremy W Jacobs, Ronan P Sugrue, Jerome Jeffrey Federspiel, et al.
Stem Cells International|September 21, 2017
Tissue Engineering to Repair Diaphragmatic Defect in a Rat ModelG P Liao, Y Choi, K Vojnits, et al.
American Journal of Perinatology|August 28, 2024
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and NewbornYosuke Komatsu, E J T Joanne Verweij, Eleonor Tiblad, et al.
JAMA Network Open|November 24, 2025
A Clinical Practice Guideline for the Management of Pregnancy Alloimmunized to Red Blood Cell AntigensKenneth J Moise, Kara B Markham, Philip C Spinella, et al.
American Journal of Hematology|September 26, 2024
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W Jacobs, Garrett S Booth, Sheharyar Raza, et al.
American Journal of Obstetrics and Gynecology|June 15, 2018
Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newbornCarolien Zwiers, Johanna G van der Bom, Inge L van Kamp, et al.
Obstetrics and Gynecology|November 9, 2016
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of PregnancyKenneth J Moise, Manisha Gandhi, Noemi H Boring, et al.
Prenatal Diagnosis|December 12, 2025
Comparison of Insertion Difficulties and Performance of Thoracoamniotic Shunts for Fetal Hydrothorax: Success and Failure Rates in Different Shunt Types for Fetal HydrothoraxTess T Treurniet, Nimrah Abbasi, Greg Ryan, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Transfusion Medicine Reviews|April 20, 2025
The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test AccuracyJeremy W Jacobs, Ronan P Sugrue, Jerome Jeffrey Federspiel, et al.
Stem Cells International|September 21, 2017
Tissue Engineering to Repair Diaphragmatic Defect in a Rat ModelG P Liao, Y Choi, K Vojnits, et al.
American Journal of Perinatology|August 28, 2024
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and NewbornYosuke Komatsu, E J T Joanne Verweij, Eleonor Tiblad, et al.
JAMA Network Open|November 24, 2025
A Clinical Practice Guideline for the Management of Pregnancy Alloimmunized to Red Blood Cell AntigensKenneth J Moise, Kara B Markham, Philip C Spinella, et al.
American Journal of Hematology|September 26, 2024
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W Jacobs, Garrett S Booth, Sheharyar Raza, et al.
American Journal of Obstetrics and Gynecology|June 15, 2018
Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newbornCarolien Zwiers, Johanna G van der Bom, Inge L van Kamp, et al.
Obstetrics and Gynecology|November 9, 2016
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of PregnancyKenneth J Moise, Manisha Gandhi, Noemi H Boring, et al.
Prenatal Diagnosis|December 12, 2025
Comparison of Insertion Difficulties and Performance of Thoracoamniotic Shunts for Fetal Hydrothorax: Success and Failure Rates in Different Shunt Types for Fetal HydrothoraxTess T Treurniet, Nimrah Abbasi, Greg Ryan, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 15